At a relatively low price of $11 million in cash and a $22 million five-year promissory note to buy Adenosine Therapeutics LLC, Clinical Data Inc. went literally overnight from a one-drug firm to a company with several therapeutic candidates in its pipeline. (BioWorld Today)